Read + Share
Amedeo Smart
Independent Medical Education
Bourne N, Keith CA, Miller AL, Pyles RB, et al. Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease. J Virol 2023;97:e0066923.PMID: 37655939
Email
LinkedIn
Facebook
Twitter
Privacy Policy